Disappearing Thread

anonymous

Guest
Anyone else notice that the conversation around Vanda stock, the secondary offering, Mihales cashing in options before the secondary drove the price down, his seat on the board that would put him in a position to know when a secondary is coming all went away?????

Hit a nerve much????

I was trying to find it to ask a follow up now that the stock is tanking how many shares he'd be selling at $14.50 and not the $19 or so a few weeks ago.
 






Am I the only one that find the timing with the Teva paragraph IV filing a bit... strange. While vanda reported receiving it after the secondary, according to the FDA, Teva filed it prior to the secondary. Hmmm...